{"pub_date": "2016-03-10T00:00:00Z", "subsection_name": "DealBook", "lead_paragraph": "Valeant said it had named three new directors to its board, including an executive from a major shareholder, Pershing Square Capital Management.", "print_page": "2", "document_type": "article", "byline": {"person": [{"rank": 1, "organization": "", "lastname": "THOMAS", "firstname": "Katie", "role": "reported"}], "original": "By KATIE THOMAS"}, "multimedia": [{"width": 190, "height": 126, "url": "images/2016/03/10/business/10valeant-web1/10valeant-web1-thumbWide.jpg", "subtype": "wide", "legacy": {"wide": "images/2016/03/10/business/10valeant-web1/10valeant-web1-thumbWide.jpg", "widewidth": "190", "wideheight": "126"}, "type": "image"}, {"width": 600, "height": 400, "url": "images/2016/03/10/business/10valeant-web1/10valeant-web1-articleLarge.jpg", "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2016/03/10/business/10valeant-web1/10valeant-web1-articleLarge.jpg"}, "type": "image"}, {"width": 75, "height": 75, "url": "images/2016/03/10/business/10valeant-web1/10valeant-web1-thumbStandard.jpg", "subtype": "thumbnail", "legacy": {"thumbnail": "images/2016/03/10/business/10valeant-web1/10valeant-web1-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "type": "image"}], "section_name": "Business Day", "headline": {"print_headline": "Valeant Takes Step to Soothe Investors", "main": "Valeant Pharmaceuticals Adds Board Members"}, "source": "The New York Times", "blog": [], "word_count": "434", "web_url": "http://www.nytimes.com/2016/03/10/business/valeant-pharmaceuticals-adds-board-members.html", "slideshow_credits": null, "news_desk": "Business", "type_of_material": "News", "snippet": "Valeant said it had named three new directors to its board, including an executive from a major shareholder, Pershing Square Capital Management.", "_id": "56e0328d38f0d836dc036bd2", "abstract": "Valeant Pharmaceuticals, which is under scrutiny for its drug-pricing practices, says it is adding three new members to its board, including one from shareholder Pershing Square Capital Management; stock rises.", "keywords": [{"rank": "1", "name": "organizations", "value": "Valeant Pharmaceuticals International Inc", "is_major": "Y"}, {"rank": "2", "name": "organizations", "value": "Pershing Square Capital Management", "is_major": "Y"}, {"rank": "3", "name": "subject", "value": "Boards of Directors", "is_major": "Y"}, {"rank": "4", "name": "subject", "value": "Appointments and Executive Changes", "is_major": "N"}]}